PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

NCT07563439 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Rhinitis Allergic

Interventions

BIOLOGICAL: Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant
BIOLOGICAL: Montanide ISA-51 placebo emulsion

Sponsor

Kazakh National Agrarian University